| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 714187 | 3,11-difluoro-6,8,13-trimethyl-8H-quino[4,3,2-kl]acridinium methosulfate | 0.0181211508101519 | 0.41508631 |
| NSC 733465 | Null | 0.0181211508101519 | 0.095969975 |
| NSC 742256 | 8-(4-Amino-1-methylbutyl)amino-2-methyl-5,6-dihydroxyquinoline, 2.3-hydrobromide, 0.8 hydrate | 0.0181211508101519 | 0.11607979 |
| NSC 743853 | Null | 0.0181211508101519 | 0.17285104 |
| NSC 92915 | ANTINEOPLASTIC-92915 | 0.0181211508101519 | 0.1442862 |
| NSC 104801 | Cytembena | 0.0208632511155816 | 0.18163093 |
| NSC 132791 | Butyric acid, 2-hydroxy-2-methyl-, 4-ester with 1,3a.beta.,4,7,7a.alpha.,11,11a,11b.alpha.-octahydro-1.alpha.,2.alpha.,4.beta.,11.beta.-tetrahydroxy-3.alpha.,8,11a.beta.-trimethyl-2H-1,11c.beta.-(epo | 0.0208632511155816 | 0.33885947 |
| NSC 374980 | Acetamide, N-[2,3-bis(acetyloxy)-5,6,7,9-tetrahydro-1-methoxy-10-(methylthio)-9-oxobenzo[a]heptalen-7-yl]-, (S)- | 0.0208632511155817 | 0.2523112 |
| NSC 375162 | Imidazo[1,2-a]pyridine-6-carboxaldehyde, 2-[4-[[(4,5-dihydro-1H-imidazol-2-yl)hydrazono]methyl]phenyl]-, (4,5-dihydro-1H-imidazol-2-yl)hydrazone, dihydroiodide | 0.0208632511155817 | 0.22596225 |
| NSC 375726 | BACCHARINOID A-1 (BUSAM) | 0.0208632511155817 | 0.40666076 |